Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
One World Products, Inc. (OWPC) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 RW Form RW - Registration Withdrawal Request:
07/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
06/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/15/2023 10-K Annual Report for the period ended December 31, 2022
10/04/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
09/07/2022 8-K Appointed a new director
Docs: "SCHEDULES",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of September 1, 2022, is entered into by and between One World Products, Inc., a Nevada corporation, , and Tysadco Partners, LLC, a Delaware limited liability company . A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended . B. Upon the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement on the date hereof , one hundred fifty thousand worth of restricted Series B...",
"TO REGISTRATION RIGHTS AGREEMENT"
08/22/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/04/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/01/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/30/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER"
11/15/2021 10-Q Quarterly Report for the period ended September 30, 2021
09/30/2021 SC 13G Ellins Craig reports a 6.4% stake in One World Pharma, Inc.
09/27/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PROMISSORY NOTE",
"COMMON STOCK PURCHASE WARRANT ONE WORLD PHARMA, INC. Warrant Shares: 1,500,000 Date of Issuance: September 24, 2021 This COMMON STOCK PURCHASE WARRANT certifies that, for value received of even date) , AJB Capital Investments, LLC, a Delaware limited liability company , is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from One World Pharma Inc. Inc., a Nevada corporation , up to 1,500,000 shares of Common Stock at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 24, 2021, by and among the Company and the Holder . Capitalized terms...",
"COMMON STOCK PURCHASE WARRANT ONE WORLD PHARMA, INC. Warrant Shares: 2,000,000 Date of Issuance: September 24, 2021 This COMMON STOCK PURCHASE WARRANT certifies that, for value received of even date) , AJB Capital Investments, LLC, a Delaware limited liability company , is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from One World Pharma Inc. Inc., a Nevada corporation , up to 2,000,000 shares of Common Stock at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 24, 2021, by and among the Company and the Holder . Capitalized terms...",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of September 24, 2021, by and between ONE WORLD PHARMA, INC., a Nevada corporation, with headquarters located at 3471 W. Oquendo Road, Suite 301, Las Vegas, NV 89118 , and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 . WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth i...",
"SECURITY AGREEMENT"
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
06/29/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
06/03/2021 8-K Quarterly results
05/17/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/15/2021 10-K Annual Report for the period ended December 31, 2020
04/01/2021 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/08/2021 8-K Quarterly results
01/25/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note of One World Pharma, Inc. in the principal amount of $290,000 issued to AJB Capital Investments LLC",
"Securities Purchase Agreement, between One World Pharma, Inc. and AJB Capital Investments LLC",
"Security Agreement, between One World Pharma, Inc. and AJB Capital Investments LLC"
11/23/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/17/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/14/2020 10-Q Quarterly Report for the period ended June 30, 2020
06/26/2020 10-Q Quarterly Report for the period ended March 31, 2020
06/09/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Release Agreement between One World Pharma, Inc. and Craig Ellins",
"Letter Agreement between One World Pharma, Inc. and Isiah L. Thomas III"
05/29/2020 10-K Annual Report for the period ended December 31, 2019
05/15/2020 8-K Other Events
05/14/2020 NT 10-K/A Form NT 10-K/A - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: [Amend]
05/08/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy